Human Microbiome Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May 2018| TMR644A| Transparency

Report Highlights

Human Microbiome Market - Overview

Human microbiome, also known as microbiota, includes microbes such as fungi, bacteria, and virus. These microbes reside in oral mucosa, saliva, gastrointestinal tracts, conjunctiva, or on the surface or in deep layers of the skin. At present, extensive research is being conducted to discover the importance of these micro-organisms in maintaining immune systems and their contribution in digestion of food. Large number of microbes reside in the large intestine, with region of the human body having a distinct community of microbes dwelling. Studies are still in progress to understand factors regulating microbial colonization in the body that are just millimeters apart. The human microbiome project (HMP) was launched in 2008 as a U.S. National Institute of Health. This was initiated to identify and characterize microbes found in the healthy and diseases human body.

This report on the global human microbiome market analyzes the future prospects of the market. The market for diagnostics and therapeutics is independently analyzed as two separate markets within the report. The market for human microbiome therapeutics is segmented based on therapeutic area and region, while the market for human microbiome diagnostics is segmented in terms of indication, technology, and region. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. A detailed qualitative analysis of factors driving and restraining the market and opportunities is provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2018 and 2026 for diagnostics and 2020 to 2026 for therapeutics, along with the compound annual growth rate (CAGR %) from 2018/2020 to 2026 are provided for all the segments. Market related factors such as estimated launch of products, drugs in the pipeline, and industry-institute collaborations in research have been taken into consideration while estimating the market size. Growth rate for each segment within the global human microbiome market has been determined after a thorough analysis of past and present trends, demographics, future trends, technological developments, clinical trials, and regulatory requirements. These factors are projected to help market players to take strategic decisions to strengthen their positions and increase share in the global market.

Based on indication, the global human microbiome diagnostics market has been segmented into gastrointestinal and metabolic disorders, women’s health, cancer, and others. The gastrointestinal & metabolic disorders segment is projected to expand at a considerable pace due to high unmet medical needs for gut health disorders and rise in population suffering from lifestyle-based metabolic diseases. In terms of technology, the market has been bifurcated into 16s rRNA sequencing and metagenomic sequencing. Both these forms have been documented to have various advantages and provide accurate testing and hence, these are likely to garner nearly equal share of the overall diagnostics market during the forecast period. Based on therapeutic area, the market has been segmented into gastrointestinal disorders, metabolic disorders, women’s health, skin disorders, and others. The others segment includes autoimmune disorders, infant health disorders, and rare diseases.

In terms of region, the global human microbiome market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been further segmented by major countries. These include the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, the UAE, and South Africa. The competition landscape section included in the report is likely to assist existing players increase their market shares and new companies to establish their presence in the human microbiome market. The report profiles major players operating in the human microbiome market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include AOBiome LLC, Osel, Inc., Seres Therapeutics, Second Genome, uBiome, Inc., Metabiomics Corp., Rebiotix, Inc., and Vedanta Biosciences.

The global human microbiome market has been segmented as follows:

Global Human Microbiome Diagnostics Market, by Indication
Gastrointestinal and Metabolic Disorders
Women’s Health
Cancer
Others

Global Human Microbiome Diagnostics Market, by Technology
16s rRNA Sequencing
Metagenomic Sequencing

Global Human Microbiome Therapeutics Market, by Therapeutic Area
Gastrointestinal Disorders
Metabolic Disorders
Women’s Health
Skin Disorders
Others

Global Human Microbiome Diagnostics and Therapeutics Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
South Africa
Rest of Middle East & Africa

  • Table 1 : Key Mergers and Acquisitions
  • Table 2 : Global Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 3 : Global Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2018–2026
  • Table 4 : Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
  • Table 5 : Global Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Region
  • Table 6 : Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Region
  • Table 7 : North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 8 : North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2018–2026
  • Table 9 : North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country, 2018–2026
  • Table 10 : North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
  • Table 11 : North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2026
  • Table 12 : Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 13 : Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2018–2026
  • Table 14 : Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Country, 2018–2026
  • Table 15 : Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
  • Table 16 : Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2026
  • Table 17 : Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 18 : Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2018–2026
  • Table 19 : Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Country, 2018–2026
  • Table 20 : Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
  • Table 21 : Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2026
  • Table 22 : Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 23 : Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2018–2026
  • Table 24 : Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country, 2018–2026
  • Table 25 : Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
  • Table 26 : Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2026
  • Table 27 : Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2018–2026
  • Table 28 : Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2018–2026
  • Table 29 : Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country, 2018–2026
  • Table 30 : Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
  • Table 31 : Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2026
  • Figure 1 : Global Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2018–2026
  • Figure 2 : Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2020–2026
  • Figure 3 : Human Microbiome Diagnostic Market Value Share by Indication (2018)
  • Figure 4 : Human Microbiome Diagnostic Market Value Share by Technology (2018)
  • Figure 5 : Human Microbiome Therapeutics Market Value Share by Therapeutic Area (2020)
  • Figure 6 : Human Microbiome Therapeutics Market Value Share by Region (2020)
  • Figure 7 : Global Human Microbiome Diagnostic Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 8 : Global GI & Metabolic Disorders Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 9 : Global Women’s Health Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 10 : Global Cancer Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 11 : Global Others Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 12 : Global Human Microbiome Diagnostic Market Attractiveness Analysis, by Indication, 2018
  • Figure 13 : Global Human Microbiome Diagnostic Market Value Share Analysis, by Technology, 2018 and 2026
  • Figure 14 : Global Human Microbiome Diagnostic Market Attractiveness Analysis, by Technology, 2018
  • Figure 15 : Global Metagenomic Sequencing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 16 : Global 16s rRNA Sequencing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 17 : Global Human Microbiome Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2026
  • Figure 18 : Global GI Disorders Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2026
  • Figure 19 : Global Metabolic Disorders Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2026
  • Figure 20 : Global Women’s Health Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2026
  • Figure 21 : Global Skin Disorders Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2026
  • Figure 22 : Global Others Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2026
  • Figure 23 : Global Human Microbiome Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2020
  • Figure 24 : Global Human Microbiome Diagnostics Market Value Share Analysis, by Region, 2018 and 2026
  • Figure 25 : Global Human Microbiome Therapeutics Market Value Share Analysis, by Region, 2020 and 2026
  • Figure 26 : Global Human Microbiome Diagnostics Market Attractiveness Analysis, by Region, 2018
  • Figure 27 : Global Human Microbiome Therapeutics Market Attractiveness Analysis, by Region, 2020
  • Figure 28 : North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2018–2026
  • Figure 29 : North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2020–2026
  • Figure 30 : North America Diagnostics Market Attractiveness Analysis, by Country, 2018
  • Figure 31 : North America Therapeutics Market Attractiveness Analysis, by Country, 2020
  • Figure 32 : North America Diagnostic Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 33 : North America Diagnostic Market Value Share Analysis, by Technology, 2018 and 2026
  • Figure 34 : North America Diagnostic Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 35 : North America Therapeutics Market Value Share Analysis by Therapeutic Area, 2020 and 2026
  • Figure 36 : North America Therapeutics Market Value Share Analysis by Country, 2020 and 2026
  • Figure 37 : North America Diagnostics Market Attractiveness Analysis, by Indication, 2018
  • Figure 38 : North America Diagnostics Market Attractiveness Analysis, by Technology, 2018
  • Figure 39 : North America Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2020
  • Figure 40 : Europe Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2018–2026
  • Figure 41 : Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2020–2026
  • Figure 42 : Europe Diagnostics Market Attractiveness Analysis, by Country, 2018
  • Figure 43 : Europe Therapeutics Market Attractiveness Analysis, by Country, 2020
  • Figure 44 : Europe Diagnostic Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 45 : Europe Diagnostic Market Value Share Analysis, by Technology, 2018 and 2026
  • Figure 46 : Europe Diagnostic Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 47 : Europe Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2026
  • Figure 48 : Europe Therapeutics Market Value Share Analysis, by Country, 2020 and 2026
  • Figure 49 : Europe Diagnostics Market Attractiveness Analysis, by Indication, 2018
  • Figure 50 : Europe Diagnostics Market Attractiveness Analysis, by Technology, 2018
  • Figure 51 : Europe Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2020
  • Figure 52 : Asia Pacific Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2018–2026
  • Figure 53 : Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2020–2026
  • Figure 54 : Asia Pacific Diagnostics Market Attractiveness Analysis, by Country
  • Figure 55 : Asia Pacific Therapeutics Market Attractiveness Analysis, by Country
  • Figure 56 : Asia Pacific Diagnostic Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 57 : Asia Pacific Diagnostic Market Value Share Analysis, by Technology, 2018 and 2026
  • Figure 58 : Asia Pacific Diagnostic Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 59 : Asia Pacific Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2026
  • Figure 60 : Asia Pacific Therapeutics Market Value Share Analysis, by Country, 2020 and 2026
  • Figure 61 : Asia Pacific Diagnostics Market Attractiveness Analysis, by Indication, 2018
  • Figure 62 : Asia Pacific Diagnostics Market Attractiveness Analysis, by Technology, 2018
  • Figure 63 : Asia Pacific Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2020
  • Figure 64 : Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2018–2026
  • Figure 65 : Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2020–2026
  • Figure 66 : Latin America Diagnostics Market Attractiveness Analysis, by Country, 2018
  • Figure 67 : Latin America Therapeutics Market Attractiveness Analysis, by Country, 2020
  • Figure 68 : Latin America Diagnostics Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 69 : Latin America Diagnostics Market Value Share Analysis, by Technology, 2018 and 2026
  • Figure 70 : Latin America Diagnostics Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 71 : Latin America Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2026
  • Figure 72 : Latin America Therapeutics Market Value Share Analysis, by Country, 2020 and 2026
  • Figure 73 : Latin America Diagnostics Market Attractiveness Analysis, by Indication, 2018
  • Figure 74 : Latin America Diagnostics Market Attractiveness Analysis, by Technology, 2018
  • Figure 75 : Latin America Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2020
  • Figure 76 : Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2018–2026
  • Figure 77 : Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2020–2026
  • Figure 78 : Middle East & Africa Diagnostics Market Attractiveness Analysis, by Country, 2018
  • Figure 79 : Middle East & Africa Therapeutics Market Attractiveness Analysis, by Country, 2020
  • Figure 80 : Middle East & Africa Diagnostics Market Value Share Analysis, by Indication, 2018 and 2026
  • Figure 81 : Middle East & Africa Diagnostics Market Value Share Analysis, by Technology, 2018 and 2026
  • Figure 82 : Middle East & Africa Diagnostics Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 83 : Middle East & Africa Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2026
  • Figure 84 : Middle East & Africa Therapeutics Market Value Share Analysis, by Country, 2020 and 2026
  • Figure 85 : MEA Diagnostics Market Attractiveness Analysis, by Indication, 2018
  • Figure 86 : MEA Diagnostics Market Attractiveness Analysis, by Technology, 2018
  • Figure 87 : MEA Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2020

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report